4,4,5,5-Tetramethyl-1,3,2-dioxaphospholane 2-Oxide, 95.0%, 1g

4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2(1H)-thione, 97%, 1mg

8-methylindolizine-2-carboxylic acid, 97%, 250mg

4,6-Difluoro-1H-indazol-3-amine, 95.0%, 250mg

2-Methyl-1-phenylbutane-1,3-dione, 95.0%, 10g

N,N,N,N-Tetramethyl-1,4-phenylenediamine, 95.0%, 10g

(S)-3-((tert-Butoxycarbonyl)amino)-4-(o-tolyl)butanoic acid, 98%, 100mg

4-(2-(1-METHYLPYRIDIN-4(1H)-YLIDENE)ETHYLIDENE)CYCLOHEXA-2,5-DIEN-1-ONE, 97.0%, 250mg

Methyl [2,2'-bipyridine]-5-carboxylate, 97%, 1g

3-(Benzyloxy)-6-bromo-2-chlorobenzaldehyde, 98%, 1g

{[5-(4-Fluorophenyl)isoxazol-3-yl]methyl}amine hydrochloride, 95.0%, 5g

N-(4-(((4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl)methyl)carbamoyl)phenyl)furan-2-carboxamide, 98%, 50mg

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)